Acute Respiratory Distress Syndrome (ARDS) occurs in both children and adults, but the management and diagnosis of Pediatric Acute Respiratory Distress Syndrome (PARDS) must consider factors which are unique to children and pediatric ICU practice. In 2015, the Pediatric Acute Lung Injury Consensus Conference (PALICC) published a definition of PARDS, along with clinical practice guidelines. Since then, there has been a wealth of new research focused on PARDS, which has prompted an update to PALICC, termed PALICC-2. This session focuses on important concepts and themes from PALICC-2 which are crucial for the clinical care of children with PARDS.
• Improve the diagnosis of pediatric ARDS
• Integrate new guidelines for the management of PARDS into current practice
• Use informatics and data science techniques appropriately in the care of children with PARDS
Guillaume Emeriaud, MD, PhD
Catherine Clark
Steven Shein, MD
Anoopindar Bhalla, MD, MSc
Elizabeth Killien, MD
Jocelyn Grunwell, MD, PhD
Nelson Sanchez-Pinto, MD, MCI
Introduction and Overview of PALICC-2
A Patient's Perspective
How Do We Account for Changing Practice with HFNC and NIV in Defining PARDS?
Lung Protective Bundles and Monitoring in PARDS
What Are the Most Important Outcomes to Follow in PARDS Patients, and Can We Modulate Them with our Therapies?
Understanding Phenotypic Heterogeneity: Can We Get to Precision-Based Care in PARDS?
PARDS in the Digital Era: Leveraging Informatics and Data Science